Geode Capital Management
BNTC icon

Geode Capital Management’s Benitec Biopharma BNTC Stock Holding History

Geode Capital Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.58M Buy
524,104
+70,729
+16% +$819K ﹤0.01% 2681
2025
Q4 		$6.11M Buy
453,375
+14,870
+3% +$206K ﹤0.01% 2666
2025
Q3 		$6.15M Buy
438,505
+23,294
+6% +$297K ﹤0.01% 2676
2025
Q2 		$4.86M Buy
415,211
+181,391
+78% +$2.54M ﹤0.01% 2748
2025
Q1 		$3.04M Buy
233,820
+36,724
+19% +$444K ﹤0.01% 2881
2024
Q4 		$2.49M Buy
197,096
+113,109
+135% +$1.22M ﹤0.01% 3053
2024
Q3 		$772K Buy
83,987
+20,012
+31% +$179K ﹤0.01% 3445
2024
Q2 		$447K Buy
63,975
+53,951
+538% +$398K ﹤0.01% 3601
2024
Q1 		$51.3K Hold
10,024
– – ﹤0.01% 4315
2023
Q4 		$32.5K Hold
10,024
– – ﹤0.01% 4442
2023
Q3 		$30.3K Buy
10,024
+7,187
+253% +$22.3K ﹤0.01% 4535
2023
Q2 		$11.5K Hold
2,837
– – ﹤0.01% 4708
2023
Q1 		$10.1K Sell
2,837
-73
-3% -$298 ﹤0.01% 4764
2022
Q4 		$8K Sell
2,910
-676
-19% -$2.29K ﹤0.01% 4857
2022
Q3 		$22K Buy
3,586
+28
+0.8% +$356 ﹤0.01% 4903
2022
Q2 		$70K Buy
3,558
+54
+2% +$1.26K ﹤0.01% 4694
2022
Q1 		$139K Buy
3,504
+68
+2% +$2.82K ﹤0.01% 4534
2021
Q4 		$153K Buy
3,436
+278
+9% +$15.5K ﹤0.01% 4591
2021
Q3 		$191K Buy
3,158
+1,129
+56% +$74.1K ﹤0.01% 4468
2021
Q2 		$146K Buy
2,029
+349
+21% +$27.3K ﹤0.01% 4452
2021
Q1 		$147K Buy
+1,680
New +$114K ﹤0.01% 4208

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management's BNTC Position: Q1 2026 in Review

Geode Capital Management increased its Benitec Biopharma (BNTC) stake by 16% in Q1 2026, buying an estimated $819K and bringing the position to 524,104 shares worth $5.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Geode Capital Management first reported a position in BNTC in Q1 2021 and has held it in 21 quarters since. The position peaked at $6.15M in Q3 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Geode Capital Management held 524,104 shares of Benitec Biopharma worth $5.58M as of Q1 2026.
  • Geode Capital Management bought 70,729 Benitec Biopharma shares in Q1 2026, an estimated $819K.
  • Benitec Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2681 holding.
  • Geode Capital Management first reported a position in Benitec Biopharma in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Benitec Biopharma position peaked at $6.15M in Q3 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.